United Kingdom · Question · Written question
UIN 188917
Drugs: Licensing
Original
Introduced
12 June 2023
Last action
20 June 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 June 2023
Summary
To ask the Secretary of State for Health and Social Care, which conditions are considered a priority by the Medicines and Healthcare products Regulatory Agency when assessing applications for new licences for medicines.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 June 2023
Written question
To ask the Secretary of State for Health and Social Care, which conditions are considered a priority by the Medicines and Healthcare products Regulatory Agency when assessing applications for new licences for medicines.
Source: Commons
20 June 2023
Answer
The Medicines and Healthcare products Regulatory Agency (MHRA) does not have a specific list of conditions to which it gives priority when reviewing applications for new medicine licenses. However, it does prioritise applications where there is a public h...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-06-12/188917
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1643760
- uk · wq-1643760 · source updated 20 June 2023